Cite
Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy.
MLA
Smeets, Esther M. M., et al. “Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy.” Cells (2073-4409), vol. 12, no. 10, May 2023, p. 1420. EBSCOhost, https://doi.org/10.3390/cells12101420.
APA
Smeets, E. M. M., Dorst, D. N., Franssen, G. M., van Essen, M. S., Frielink, C., Stommel, M. W. J., Trajkovic-Arsic, M., Cheung, P. F., Siveke, J. T., Wilson, I., Mascioni, A., Aarntzen, E. H. J. G., & van Lith, S. A. M. (2023). Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy. Cells (2073-4409), 12(10), 1420. https://doi.org/10.3390/cells12101420
Chicago
Smeets, Esther M. M., Daphne N. Dorst, Gerben M. Franssen, Merijn S. van Essen, Cathelijne Frielink, Martijn W. J. Stommel, Marija Trajkovic-Arsic, et al. 2023. “Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy.” Cells (2073-4409) 12 (10): 1420. doi:10.3390/cells12101420.